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ABSTRACT 
 
 
 
 
 Hydroxylated coumarins and chalcones are known to possess potent 
antioxidant activities. The present study highlights the synthesis of two 
hydroxycoumarins namely 3-acetyl-7-hydroxycoumarin and 3-acetyl-6-
hydroxycoumarin. Both compounds were synthesized using the Knoevenagel 
condensation method with respective hydroxybenzaldehydes under basic conditions. 
The synthesized hydroxycoumarins served as an intermediate for the subsequent 
coupling reaction to produce three new coumarinyl chalcones known as 7-hydroxy-3-
[3-(4ʹ-hydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-2-one, 6-hydroxy-3-[3-(4ʹ-
hydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-2-one and 7-hydroxy-3-[3-(3ʹ,4ʹ-
dihydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-2-one respectively. The target 
products were synthesized via the Claisen-Schmidt condensation reaction utilizing the 
Lewis acid, boron trifluoride-etherate (BF3-Et2O) in 1,4-dioxane. The structures of the 
synthetic compounds were confirmed by spectroscopic techniques which includes the 
Infrared (IR) and Nuclear Magnetic Resonance (NMR) (1H, 13C and DEPT) 
Spectroscopies. The antioxidant activities of all synthesized compounds were 
evaluated using three antioxidant assays known as the 2,2-diphenyl-1-picrylhydrazyl 
(DPPH), 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and Ferric 
Reducing Ability of Plasma (FRAP) assays using the Bio-Tek Epoch microplate 
reader. Among the compounds tested, the coumarinyl chalcones exhibited a better 
antioxidant activity compared to the hydroxycoumarins. 7-Hydroxy-3-[3-(3ʹ,4ʹ-
dihydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-2-one proved to be the best 
antioxidant in all assays with SC50 values of 0.57 mM and 0.036 mM in the ABTS and 
DPPH assays respectively. The FRAP value of this compound falls between the range 
of 0.09 mM to 1.67 mM. The values were comparable with the positive control used 
in these assays known as butylated hydroxyanisole (BHA). 
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ABSTRAK 
 
 
 
 
 Hidroksi kumarin dan kalkon terkenal dengan aktiviti antioxidan yang kuat. 
Kajian ini menonjolkan hasil sintesis bagi dua hidroksikumarin yang bernama 3-asetil-
7-hidroksikumarin dan 3-asetil-6-hidroksikumarin. Kedua-dua sebatian ini disintesis 
menggunakan kaedah kondensasi Knoevenagel dengan hidroksibenzaldehid masing-
masing dalam keadaan bes. Dua hidroksikumarin yang disintesis ini digunakan sebagai 
sebatian perantara untuk tindak balas penggandingan yang dilakukan berikutnya untuk 
menghasilkan tiga sebatian kumarinil kalkon yang masing-masing dikenali sebagai 7-
hidroksi-3-[3-(4ʹ-hidroksifenil)prop-2-enoil]-2H-1-benzopiran-2-on, 6-hidroksi-3-[3-
(4ʹ-hidroksifenil)prop-2-enoil]-2H-1-benzopiran-2-on dan 7-hidroksi-3-[3-(3ʹ,4ʹ-
dihidroksifenil)prop-2-enoil]-2H-1-benzopiran-2-on. Ketiga-tiga sebatian sasaran 
disintesis melalui reaksi kondensasi Claisen-Schmidt dengan menggunakan sejenis 
asid Lewis, boron-trifluorida eterat (BF3-Et2O) dalam 1,4-dioksan. Struktur sebatian 
sintetik ini disahkan menggunakan teknik spektroskopi termasuk Spektroskopi 
Inframerah (IR) dan Resonans Magnet Nukleus (NMR) (1H, 13C dan DEPT). Penilaian 
antioksidan ke atas sebatian yang disintesis juga dijalankan menerusi tiga ujian 
antioksidan iaitu ujian 2,2-difenil-1-pikrilhidrazil (DPPH), ujian 2,2'-azinobis-(3-
etilbenzotiazolin-6-asid sulfonik) (ABTS) dan ujian Kemampuan Plasma Menurunkan 
Ferik (FRAP) menggunakan Bio-Tek pembaca mikroplat Epoch. Antara semua 
sebatian yang diuji, sebatian kumarinil kalkon menunjukkan aktiviti antioksidan yang 
lebih tinggi berbanding sebatian hidroksikumarin.7-Hidroksi-3-[3-(3ʹ,4ʹ-
dihidroksifenil)prop-2-enoil]-2H-1-benzopiran-2-on terbukti menjadi antioksidan 
terbaik dalam semua ujian antioksidan yang dijalankan dengan bacaan SC50 0.57 mM 
dan 0.036 mM masing-masing dalam ujian ABTS dan ujian DPPH. Nilai FRAP 
sebatian ini ialah antara 0.09 mM hingga 1.67 mM. Nilai-nilai ini dapat dibandingkan 
dengan kawalan positif yang digunakan dalam ujian-ujian ini yang dikenali sebagai 
butil hidroksianisol (BHA).  
 
 
  
vi 
 
 
 
 
 
 
 
TABLE OF CONTENT 
 
 
 
 
CHAPTER TITLE  PAGE 
    
 DECLARATION  ii 
 ACKNOWLEDGEMENT  iii 
 ABSTRACT  iv 
 ABSTRAK  v 
 TABLE OF CONTENTS  vi 
 LIST OF TABLES  ix 
 LIST OF SCHEMES  x 
 LIST OF FIGURES  xii 
 LIST OF ABBREVIATIONS  xiii 
 LIST OF APPENDICES  xiv 
    
1 INTRODUCTION   
 1.1 Background of Study  1 
 1.2 Problem Statement   3 
 1.3 Objectives of Study  4 
 1.4 Scope of Study  4 
 1.5 Significance of Study  5 
    
2 LITERATURE REVIEW   
 2.1 Chalcones  6 
  2.1.1 Naturally Occurring Chalcones  7 
  2.1.2 Biosynthesis of Chalcones  11 
  2.1.3 Biological Activities of Chalcones  13 
  2.1.4 Synthesis of Chalcones  15 
 2.2 Coumarins  19 
vii 
 
 
  2.2.1 Naturally Occurring Coumarins  21 
  2.2.2 Biosynthesis of Coumarins  23 
  2.2.3 Biological Activities of Coumarins  25 
  2.2.4 Synthesis of Coumarins  26 
 2.3 Coumarinyl Chalcones  28 
  2.3.1 Biological Activities of Coumarinyl 
Chalcones 
 29 
  2.3.2 Synthesis of Coumarinyl Chalcones  30 
 2.4 Antioxidant Activity  32 
  2.4.1 Ferric Reducing Ability of Plasma 
(FRAP) 
 33 
  2.4.2 2,2'-Azinobis-(3-ethylbenzothiazoline-6-
sulfonic acid) (ABTS)  
 34 
  2.4.3 2,2-Diphenyl-1-picrylhydrazyl (DPPH) 
Free Radicals 
 34 
    
3 RESULTS AND DISCUSSION   
 3.1 Synthesis of Hydroxycoumarins  36 
  3.1.1 Synthesis of 3-acetyl-7-hydroxycoumarin 
(97) and 3-acetyl-6-hydroxycoumarin 
(98) 
 36 
 3.2 The Synthesis of Hydroxylated Coumarinyl 
Chalcones 
 40 
  3.2.1 Synthesis of 7-Hydroxy-3-[3-(4ʹ-
hydroxyphenyl)prop-2-enoyl]-2H-1-
benzopyran-2-one (105), 6-Hydroxy-3-
[3-(4ʹ-hydroxyphenyl)prop-2-enoyl]-2H-
1-benzopyran-2-one (106) and 7-
Hydroxy-3-[3-(3ʹ,4ʹ-dihydroxyphenyl) 
prop-2-enoyl]-2H-benzopyran-2-one 
(112) 
 40 
 3.3 Antioxidant Properties of the Synthesized 
Compounds 
 47 
viii 
 
 
  3.3.1 FRAP Assay  48 
  3.3.2 ABTS Assay  50 
  3.3.3 DPPH Assay  51 
  3.3.4 Structural Features related to Antioxidant 
Properties 
 53 
      
4 EXPERIMENTAL    
 4.1 General Procedures  55 
 4.2 Instrumentations  55 
 4.3 Solvents and Chemicals  56 
 4.4 Synthesis of 3-Acetyl-7-hydroxycoumarin (97)  56 
 4.5 Synthesis of 3-Acetyl-6-hydroxycoumarin (98)  57 
 4.6 Synthesis of 7-Hydroxy-3-[3-(4ʹ-
hydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-
2-one (105) 
 57 
 4.7 Synthesis of 6-Hydroxy-3-[3-(4ʹ-
hydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-
2-one (106) 
 58 
 4.8 Synthesis of 7-Hydroxy-3-[3-(3ʹ,4ʹ-
dihydroxyphenyl)prop-2-enoyl]-2H-1-
benzopyran-2-one (112) 
 59 
 4.9 Antioxidant Assays  59 
  4.9.1 FRAP Assay  60 
  4.9.2 ABTS Assay  60 
  4.9.3 DPPH Assay  61 
  4.9.4 Statistical Analysis  61 
      
5 CONCLUSION AND RECOMMENDATIONS   
 5.1 Conclusion   62 
 5.2 Recommendations  63 
    
REFERENCES  64 
Appendices 1 - 27 76-102 
  
ix 
 
 
 
 
 
 
 
LIST OF TABLES 
 
 
 
 
TABLE NO. TITLE  PAGE 
 
 
 
2.1  Classification of Coumarins and Their Structures  20 
3.1  Ferric Reducing Antioxidant Power (FRAP) 
Results 
 49 
3.2  ABTS Radical Scavenging Results  51 
3.3  DPPH Radical Scavenging Results  52 
 
  
x 
 
 
 
 
 
 
 
LIST OF SCHEMES 
 
 
 
 
SCHEME NO. TITLE  PAGE 
 
 
 
2.1  Isomerization of the Chalcone-Flavanone System  7 
2.2  The Biosynthetic Pathway of 2ʹ,4ʹ,4,6ʹ-
Tetrahydroxychalcone 
 12 
     
2.3  Synthesis of Chalcone via Claisen-Schmidt 
condensation 
 15 
     
2.4  Solvent-free reaction to produce Substituted 
Chalcones 
 16 
     
2.5  Synthesis of Chalcones using SOCl2 and EtOH as 
catalysts 
 16 
     
2.6  Synthesis of 4,4ʹ-Dihydroxychalcone using BF3-
Et2O 
 17 
     
2.7  The Algar-Flynn-Oyamada reaction to produce 
Aurones (51) and Flavones (52) 
 18 
     
2.8  Biosynthesis of Coumarin  24 
2.9  Synthesis of Coumarins via Perkin reaction  26 
2.10  Pechmann condensation  26 
2.11  Pechmann Synthesis carried out by Maheshwara 
et al. (2006) [81] 
 27 
     
2.12  Knoevenagel condensation in the presence of an 
Ionic Liquid 
 27 
     
2.13  Classic Knoevenagel condensation  28 
2.14  Synthesis method of Coumarinyl Chalcones  31 
2.15  Claisen-Schmidt condensation to produce 
Coumarinyl Chalcones 
 32 
     
3.1  Reaction to synthesize hydroxycoumarins (97) 
and (98) 
 37 
xi 
 
 
     
3.2  Reaction mechanism to produce 
hydroxycoumarins (97) and (98) 
 39 
     
3.3  Synthesis of Coumarinyl Chalcones (105), (106) 
and (112) 
 41 
     
3.4  Proposed dissociation process of BF3 complex  42 
3.5  Reaction mechanism to produce Coumarinyl 
Chalcones (105) and (106) 
 45 
     
3.6  Reaction mechanism to generate ABTS radicals 
and its Electron Transfer process 
 50 
     
3.8  DPPH radical scavenging action  51 
3.9  Proposed mechanism of Antioxidant Capacity of 
Compound (112) 
 54 
     
 
 
 
 
xii 
 
 
 
 
 
 
 
 
LIST OF FIGURES 
 
 
 
 
FIGURE NO. TITLE  PAGE 
 
 
 
3.1  FeSO4 Calibration Curve  49 
     
  
xiii 
 
 
 
 
 
 
 
 
LIST OF ABBREVIATIONS 
 
 
 
 
λ - Wavelength 
ABTS - 2,2ʹ-Azinobis-(3-ethyl-benzothiazoline-6-sulfonic acid)  
Ac2O - Acetic Anhydride 
BHA - Butylated Hydroxy Anisole 
CC - Column Chromatography 
COSY - Correlation Spectroscopy 
13C-DEPT - Carbon-13 Distortionless Enhancement by Polarization 
Transfer 
13C-NMR - Carbon-13 Nuclear Magnetic Resonance Spectroscopy 
DPPH - 2,2-Diphenyl-1-picrylhydrazyl 
ESR - Electron Spin Resonance 
EtOAc - Ethyl Acetate 
EtOH - Ethanol 
FRAP - Ferric Reducing Ability of Plasma  
1H-NMR - Proton Nuclear Magnetic Resonance Spectroscopy 
IR - Infrared Spectroscopy 
J - Coupling Constant 
EtOK - Potassium Acetate 
EtONa - Sodium Acetate 
ORAC - Oxygen Radical Absorbance Capacity 
PAL - Phenylalanine Ammonia Lyase 
PMN - Polymorphonucleate 
TLC - Thin Layer Chromatography 
UDP - Uridine Diphosphate 
UV - Ultraviolet 
  
xiv 
 
 
 
 
 
 
 
 
LIST OF APPENDICES 
 
 
 
 
APPENDIX TITLE  PAGE 
 
 
 
1  IR spectrum of 3-acetyl-7-hydroxycoumarin (97)  76 
2  1H NMR spectrum of 3-acetyl-7-hydroxycoumarin (97)  77 
3  1H NMR spectrum of 3-acetyl-7-hydroxycoumarin (97) 
(Expansion) 
 78 
4  IR spectrum of 3-acetyl-6-hydroxycoumarin (98)  79 
5  1H NMR spectrum of 3-acetyl-6-hydroxycoumarin (98)  80 
6  1H NMR spectrum of 3-acetyl-6-hydroxycoumarin (98) 
(Expansion) 
 81 
7  IR spectrum of 7-Hydroxy-3-[3-(4ʹ-hydroxyphenyl) prop-
2-enoyl]-2H- benzopyran-2-one (105) 
 82 
8  1H NMR spectrum of 7-Hydroxy-3-[3-(4ʹ-hydroxyphenyl) 
prop-2-enoyl]-2H-1-benzopyran-2-one (105) (Expansion) 
 83 
9  1H NMR spectrum of 7-Hydroxy-3-[3-(4ʹ-hydroxyphenyl) 
prop-2-enoyl]-2H-1-benzopyran-2-one (105) 
 84 
10  COSY spectrum of 7-Hydroxy-3-[3-(4ʹ-hydroxyphenyl) 
prop-2-enoyl]-2H-1-benzopyran-2-one (105) (Expansion) 
 85 
11  13C NMR spectrum of 7-Hydroxy-3-[3-(4ʹ-hydroxyphenyl) 
prop-2-enoyl]-2H-1-benzopyran-2-one (105) 
 86 
xv 
 
 
 
12  13C NMR spectrum of 7-Hydroxy-3-[3-(4ʹ-hydroxyphenyl) 
prop-2-enoyl]-2H-1-benzopyran-2-one (105) (Expansion) 
 87 
13  13C NMR and DEPT spectra of 7-Hydroxy-3-[3-(4ʹ-
hydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-2-one 
(105) 
 88 
14  IR spectrum of 6-Hydroxy-3-[3-(4ʹ-hydroxyphenyl)prop-2-
enoyl]-2H- benzopyran-2-one (106) 
 89 
15  1H NMR spectrum of 6-Hydroxy-3-[3-(4ʹ-hydroxyphenyl) 
prop-2-enoyl]-2H-1-benzopyran-2-one (106) 
 90 
16  1H NMR spectrum of 6-Hydroxy-3-[3-(4ʹ-hydroxyphenyl) 
prop-2-enoyl]-2H-1-benzopyran-2-one (106) (Expansion) 
 91 
17  COSY spectrum of 6-Hydroxy-3-[3-(4ʹ-hydroxyphenyl) 
prop-2-enoyl]-2H-1-benzopyran-2-one (106) (Expansion) 
 92 
18  13C NMR spectrum of 6-hydroxy-3-[3-(4ʹ-hydroxyphenyl) 
prop-2-enoyl]-2H-1-benzopyran-2-one (106) 
 93 
19  13C NMR spectrum of 6-hydroxy-3-[3-(4ʹ-hydroxyphenyl) 
prop-2-enoyl]-2H-1-benzopyran-2-one (106) (Expansion) 
 94 
20  13C NMR and DEPT spectrum of 6-hydroxy-3-[3-(4ʹ-
hydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-2-one 
(106) 
 95 
21  IR spectrum of 7-Hydroxy-3-[3-(3ʹ,4ʹ-dihydroxyphenyl) 
prop-2-enoyl]-2H- benzopyran-2-one (112) 
 96 
22  1H NMR spectrum of 7-Hydroxy-3-[3-(3ʹ,4ʹ-
dihydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-2-one 
(112) 
 97 
23  1H NMR spectrum of 7-Hydroxy-3-[3-(3ʹ,4ʹ-
dihydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-2-one 
(112) (Expansion) 
 98 
xvi 
 
 
 
24  COSY spectrum of 7-Hydroxy-3-[3-(3ʹ,4ʹ-
dihydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-2-one 
(112) (Expansion) 
 99 
25  13C NMR spectrum of 7-Hydroxy-3-[3-(3ʹ,4ʹ-
dihydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-2-one 
(112) 
 100 
26  13C NMR spectrum of 7-Hydroxy-3-[3-(3ʹ,4ʹ-
dihydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-2-one 
(112) (Expansion) 
 101 
27  13C NMR and DEPT spectra of 7-Hydroxy-3-[3-(3ʹ,4ʹ-
dihydroxyphenyl)prop-2-enoyl]-2H-1-benzopyran-2-one 
(112) 
 102 
 
 
 
 
  
 
 
 
 
 
 
 
CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Background of Study 
 
 
Naturally occurring compounds are produced as a result of biodiversity in 
which organisms interact with their surroundings to yield various chemical entities 
necessary for the organisms to survive [1]. Chalcone is a class of natural compounds 
that can be isolated from various plant species and their existence in the plant kingdom 
is vast. Chalcones are also known by the name of 1,3-diaryl-2-propen-1-one (1) [2]. 
There are quite a number of natural and synthetic chalcones that display useful 
bioactivities which includes cytotoxicity, chemoprotective, antibacterial, antifungal, 
antiviral and antiflammatory properties [3]. Based on the biosynthesis of flavonoids in 
plants, chalcones  exist  as an intermediate as well as the final product [2].  
 
 
O
(1)  
 
 
 
Another class of naturally occurring compounds is known as coumarin (2) or 
1,2-benzopyrone. Naturally occurring coumarins are some of the most abundant 
chemicals in natural products [4]. It is the parent molecule of the compound 
dicoumarol. Compound (2) has the simplest structure within a huge class of phenolic 
compounds and they consist of a benzene ring fused to an α-pyrone ring [5]. 
2 
 
 
 
Previous reports have showed that compound (2) and its several simple 
derivatives have antitumor properties. The biological and pharmacological effects of 
these compounds largely depends on the position and the type of substituents attached 
to the compound [6]. Some reports have shown that coumarins possessed 
antimicrobial, inhibited lipooxygenase and cyclooxygenase metabolic pathways, 
antioxidant, inflammatory and antitumoral activities [7, 8].  
 
 
O O
(2)  
 
 
A wide range of natural products such as the ones mentioned above can be 
taken as chemical scaffolds as they are able to provide templates with high potential 
for combinatorial chemistry since they have the ability to display chemical information 
in a three-dimensional space. These countless drug classes aids therapeutic areas of 
infectious diseases and oncology as they are able to interact with numerous specific 
targets within the cell. Also, for many years, they have been deliberated as the base 
molecules in the process of drug discovery and development. Libraries are constructed 
with a basis of those scaffolds thus having the potential for both lead discovery and 
lead optimization. In lead discovery the compound is hoped to have an effect against 
targets unrelated to the original activity of the natural product and in lead optimization 
the compound is derivatized with the hope of improving its properties over the natural 
product [9]. 
 
 
Nowadays, hybrid molecules are the current trend in drug development. 
Several biological characteristics are able to be observed with these hybrid molecules. 
Recently, several reports proposed that coumarins having coupled with other 
molecules possessing a different biological activity will exhibit dual bioactivities. The 
coupling process will also enhance the properties of compounds to exhibit activities 
such as antiplatelet, antioxidant and anti-inflammatory activities [10 - 12].   
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In recent years, the demands for natural product inspirited drug-like molecules 
or their libraries have hiked and therefore, it imposes the necessity for the development 
of reaction sequences and linking strategies that allow complex and assorted target 
molecules to be constructed in a more facile and reliable manner [13]. Therefore, the 
overall mission or target in any organic synthesis is to build or construct any organic 
molecules that are desired. Synthesizing bioactive natural compounds are among the 
goal in doing organic synthesis. Presently, organic synthesis is considered to be very 
important since natural products synthesis is not the only pathway to synthesis 
compounds having useful properties anymore. Organic synthesis has also evolved that 
some useful properties are able to be discovered due to the synthetic studies conducted 
[2]. 
 
 
 
 
1.2 Problem Statement 
 
 
Recent developments in pharmacology are looking into the coupling or 
combination of two pharmacophores within a molecule. These combinations allow the 
availability of active sites that are able to accommodate two different targets within 
the same molecule. The coupling of these pharmacophores provides a way to surpass 
drug resistance [14] and lowering the emergence of new resistant strains [15]. Cellular 
oxidative stress are created due to a rise in free radicals, it plays an important role in 
the aging process through pathogenesis apart from other diseases which includes 
cancer, atherosclerosis, diabetes and Alzheimer’s disease [16, 17]. Hence, it would be 
intriguing to synthesize hybrid molecules and investigate whether these molecules are 
able to relieve oxidative stress as the research and development of antioxidants have 
drawn a great deal of attention in recent years [18]. 
 
  
4 
 
 
 
1.3 Objectives of Study 
 
 
This study was designed based on the following objectives: 
(a) To synthesize hydroxycoumarins and hydroxylated coumarinyl chalcones. 
(b) To characterize the structure of synthetic compounds using Nuclear Magnetic 
Resonance (NMR) and Infrared Spectroscopies (IR). 
(c) To evaluate the antioxidant properties of all synthesized compounds. 
 
 
 
 
1.4 Scope of Study 
 
 
The synthesis of hydroxycoumarins involved the usage of 2,4-
dihydroxybenzaldehyde (3), 2,5-dihydroxybenzaldehyde (4) and ethyl acetoacetate (5) 
as the starting materials. Piperidine and glacial acetic acid acted as the catalyst and co-
catalyst respectively. The subsequent reaction to produce the desired coumarinyl 
chalcones utilized the synthetic hydroxycoumarins with either 4-
hydroxybenzaldehyde (6) or 3,4-dihydroxybenzaldehyde (7) as the starting materials. 
The catalyst used was the Lewis acid, boron-trifluoride etherate (BF3-Et2O) and 
dioxane acted as the solvent. The reactions were monitored by means of the thin layer 
chromatographic (TLC) technique and column chromatography (CC) was adapted for 
the purification process.  
 
 
OH
H
O
O
O O
(5)
(6)
H
O
OH
OH
(7)
OHOH
H
O
OH
H
O
OH
(3) (4)
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The synthetic compounds were analysed using several spectroscopic methods 
which consisted of infrared (IR) spectroscopy, 1D NMR (1H, 13C and DEPT) and 2D 
NMR (COSY). All products are tested for their antioxidant activities using the Ferric 
Reducing Ability of Plasma (FRAP), the 2,2ʹ-azinobis-(3-ethylbenzothiazoline-6-
sulfonic acid) (ABTS) and 2,2 diphenyl-1-picrylhydrazyl (DPPH) assays. All of these 
assays were monitored using the Bio-Tek Epoch microplate reader. 
 
 
 
 
1.5 Significance of Study 
 
 
Coumarins are a type of heterocyclic molecules that positively impact the 
human health. The effects imposed by these compounds are due to the radical 
scavenging properties which are mostly connected with their antioxidant activities 
[19]. A number of publications reported the antioxidant activity of chalcones, 
particularly hydroxylated chalcones [20-24]. These studies indicate that 
hydroxychalcones are a potent radical scavenger [18]. The antioxidant properties are 
related closely to the radical scavenging potentials of these compounds and they are 
affected greatly by the substituents attached to the compounds. Much of this significant 
property is observed in compounds having hydroxyl groups or oxygenated substituents 
[25]. Therefore, this research is dedicated to synthesize several derivatives of natural 
hydroxycoumarins and also hybrid molecules known as coumarinyl chalcone which 
will have hydroxyl moieties. These compounds are expected to possess potent 
antioxidant properties. Through the development of these antioxidants, a cure for all 
free radical related diseases could be found or at least the risks of inflicting them could 
be minimized.  
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